Molecular profiles of different PD-L1 expression in patients with esophageal squamous cell carcinoma

BACKGROUND: PD-1/PD-L1 inhibitors are approved treatments for patients with esophageal squamous cell carcinoma (ESCC). The present investigation aspired to explore the interrelation between molecular phenotype and PD-L1 expression in ESCC. METHODS: PD-L1 testing and targeted next-generation sequenci...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Songchen, Hu, Xintong, Zhou, Peiwen, Li, Ang, Chen, Liguo, Wang, Duo, He, Jiaxue, Jiang, Yanfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515684/
https://www.ncbi.nlm.nih.gov/pubmed/38032149
http://dx.doi.org/10.1080/15384047.2023.2256927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515684/
https://www.ncbi.nlm.nih.gov/pubmed/38032149
http://dx.doi.org/10.1080/15384047.2023.2256927

Ejemplares similares